1.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0507000369, NCT00337987
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 15232B, NCT00515528
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200541, NCT00703105
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200732, NCT00726037
|
|
5.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: E7272-701, NCT01127451
|
|
6.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 4 to 55
Sponsor: NCI, Other
Protocol IDs: UPCC 04511, NCT01343043
|
|
7.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 20 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: E7777-J081-101, NCT01401530
|
|
8.
|
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB 0509084, NCT00254332
|
Mobile | Español
